Your guide to IP issues in Germany
Effective management of pharmaceutical and biotechnology inventions involves considering issues such as patentability, data protection, enforcement, experimental use and branding. Christine Kanz and Anja Lunze of Reimann Osterrieth Köhler Haft explain how these issues are addressed in Germany
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: